GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Sernova Corp (OTCPK:SEOVF) » Definitions » Loans Receivable

Sernova (Sernova) Loans Receivable : $0.00 Mil (As of Jan. 2024)


View and export this data going back to 1998. Start your Free Trial

What is Sernova Loans Receivable?

Sernova's Loans Receivable for the quarter that ended in Jan. 2024 was $0.00 Mil.


Sernova Loans Receivable Historical Data

The historical data trend for Sernova's Loans Receivable can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Sernova Loans Receivable Chart

Sernova Annual Data
Trend Oct14 Oct15 Oct16 Oct17 Oct18 Oct19 Oct20 Oct21 Oct22 Oct23
Loans Receivable
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

Sernova Quarterly Data
Apr19 Jul19 Oct19 Jan20 Apr20 Jul20 Oct20 Jan21 Apr21 Jul21 Oct21 Jan22 Apr22 Jul22 Oct22 Jan23 Apr23 Jul23 Oct23 Jan24
Loans Receivable Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Sernova Loans Receivable Calculation

Loans Receivable are the funds that a company has lent but have not yet been repaid.


Sernova Loans Receivable Related Terms

Thank you for viewing the detailed overview of Sernova's Loans Receivable provided by GuruFocus.com. Please click on the following links to see related term pages.


Sernova (Sernova) Business Description

Traded in Other Exchanges
Address
700 Collip Circle, The Stiller Centre, Suite 114, London, ON, CAN, N6G 4X8
Sernova Corp is a clinical-stage company developing products for the treatment of chronic debilitating diseases. The company is engaged in the research and development of its proprietary Cell Pouch and associated technologies including immune-protected therapeutic cells. The Cell Pouch is a scalable, implantable medical device designed to create a vascularized tissue environment for the transplantation and engraftment of therapeutic cells, which then release proteins and or hormones for the long-term treatment of multiple serious, chronic diseases such as diabetes, hemophilia, and thyroid disease.